<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>
	<title>ZPEER INC.</title>
	<language>en_US</language>
	<generator>PRN Asia</generator>
	<description><![CDATA[we tell your story to the world!]]></description>
		<item>
		<title>Nearly 3 in 10 Veterinarians at Japan's Larger Companion-Animal Hospitals Say Their Current Pace Is Unsustainable, Zpeer Survey Finds</title>
		<author></author>
		<pubDate>2026-08-05 21:00:00</pubDate>
		<description><![CDATA[TOKYO, August 5, 2026 /PRNewswire/ -- Zpeer Inc., operator of Vetpeer — Japan's 
largest online community for veterinary professionals, reaching approximately 
80% of the country's small-animal veterinarians —today released the results of 
a survey of 314 companion-animal veterinarians on their workload and the 
service categories they want to grow or shrink.

Key findings:


 * Workload pressure rises with clinic size. While 36% of all respondents 
describe themselves as busy, only 6% of solo practitioners say their pace is 
unsustainable. At hospitals with four or more veterinarians, that share climbs 
to nearly 3 in 10.


 * Veterinarians want to grow preventive care. The single category vets most 
want to expand is wellness exams (35%), followed by endectocide prescriptions 
(20%) and combination vaccinations (18%). The busiest vets lean instead toward 
complete & therapeutic diet prescriptions — a category staff can help deliver.


 * They want less in-clinic pet boarding. Among vets whose clinics offer 
boarding, 33% want to scale it back — non-medical work with a heavy staff 
burden. "Japanese veterinarians are telling us exactly where they want to grow: 
preventive care. For manufacturers and service providers, that is an 
invitation. But the busiest hospitals have no staff time to spare — offerings 
that respect that constraint will be the ones that succeed," said Toshiya 
Morino, CEO of Zpeer Inc.

The full article — including charts, category-level data and the survey 
methodology — is available on Zpeer's website:

https://vetpeer.info/pages/japan-vet-insights-2026-08 
<https://vetpeer.info/pages/japan-vet-insights-2026-08>

Additional breakdowns by clinic size, role and age band are available on 
request. Zpeer conducts custom surveys and market studies of the Japanese 
veterinary market for animal health and pet care companies:support@zpeer.info 
<mailto:support@zpeer.info>

About Zpeer Inc.

Zpeer Inc. (https://zpeer.info/en/ <https://zpeer.info/en/>), founded in 2013 
and headquartered in Tokyo, operates Vetpeer — Japan's largest online community 
for veterinary professionals, registered by approximately 80% of the country's 
small-animal veterinarians — and provides market research, marketing and sales 
support services for animal health companies.

Media Contact:
Public Relations, Zpeer Inc.
Email: support@zpeer.info <mailto:support@zpeer.info>

]]></description>
		<detail><![CDATA[<p><span class="legendSpanClass">TOKYO</span>, <span class="legendSpanClass">August 5, 2026</span> /PRNewswire/ -- Zpeer Inc., operator of&nbsp;Vetpeer — Japan's largest online community for veterinary professionals, reaching approximately 80% of the country's small-animal veterinarians — <span id="spanHghlt8ff6">today </span>released the results of a survey of 314 companion-animal veterinarians on their workload and the service categories they want to grow or shrink.</p> 
<p>Key findings:</p> 
<ul type="disc"> 
 <li><b>Workload pressure rises with clinic size.</b> While 36% of all respondents describe themselves as busy, only 6% of solo practitioners say their pace is unsustainable. At hospitals with four or more veterinarians, that share climbs to nearly 3 in 10.<br /><br /></li> 
 <li><b>Veterinarians want to grow preventive care.</b> The single category vets most want to expand is wellness exams (35%), followed by endectocide prescriptions (20%) and combination vaccinations (18%). The busiest vets lean instead toward complete &amp; therapeutic diet prescriptions — a category staff can help deliver.<br /><br /></li> 
 <li><b>They want less in-clinic pet boarding.</b> Among vets whose clinics offer boarding, 33% want to scale it back — non-medical work with a heavy staff burden.</li> 
</ul> 
<p>&quot;Japanese veterinarians are telling us exactly where they want to grow: preventive care. For manufacturers and service providers, that is an invitation. But the busiest hospitals have no staff time to spare — offerings that respect that constraint will be the ones that succeed,&quot; said Toshiya Morino, CEO of Zpeer Inc.</p> 
<p>The full article — including charts, category-level data and the survey methodology — is available on Zpeer's website:</p> 
<p><a href="https://vetpeer.info/pages/japan-vet-insights-2026-08" target="_blank" rel="nofollow" style="color: #0000FF"><b>https://vetpeer.info/pages/japan-vet-insights-2026-08</b></a></p> 
<p>Additional breakdowns by clinic size, role and age band are available on request. Zpeer conducts custom surveys and market studies of the Japanese veterinary market for animal health and pet care companies: <a href="mailto:support@zpeer.info" target="_blank" rel="nofollow" style="color: #0000FF">support@zpeer.info</a></p> 
<p><b>About Zpeer Inc.</b></p> 
<p>Zpeer Inc. (<a href="https://zpeer.info/en/" target="_blank" rel="nofollow" style="color: #0000FF">https://zpeer.info/en/</a>), founded in 2013 and headquartered in Tokyo, operates Vetpeer — Japan's largest online community for veterinary professionals, registered by approximately 80% of the country's small-animal veterinarians — and provides market research, marketing and sales support services for animal health companies.</p> 
<p>Media Contact:<br />Public Relations, Zpeer Inc.<br />Email: <a href="mailto:support@zpeer.info" target="_blank" rel="nofollow" style="color: #0000FF">support@zpeer.info</a></p>]]></detail>
		<source><![CDATA[Zpeer Inc.]]></source>
	</item>
		<item>
		<title>Zpeer Launches A-DHA-PT™, a High-Concentration DHA Supplement for Dogs, and Announces Research Collaboration with the University of Tokyo</title>
		<author></author>
		<pubDate>2026-01-06 21:00:00</pubDate>
		<description><![CDATA[TOKYO, Jan. 6, 2026 /PRNewswire/ -- Zpeer Inc. (Headquarters: Shibuya, Tokyo; 
CEO:Toshiya Morino), an animal health company focused on evidence-based 
therapeutic innovation, has recently announced the launch of A-DHA-PT™ 
(pronounced "ay-dapt"), a high-concentration DHA supplement designed to support 
canine neurological health. The company also disclosed a new research 
collaboration with theUniversity of Tokyo aimed at further validating the 
clinical benefits of DHA in dogs with idiopathic epilepsy.

A-DHA-PT™ was developed to address growing clinical interest in nutritional 
approaches to neurological conditions in companion animals. Each compact 13 mm 
capsule delivers a high dose of over 150 mg of DHA, enabling efficient 
administration while minimizing pill burden for dogs. The product is available 
in bags containing 120 capsules.

The product's formulation is based on prior academic research* and has been 
developed under the scientific supervision of Dr.Tomohiro Yonezawa, Associate 
Professor of theUniversity of Tokyo. A-DHA-PT™ is manufactured in Japan using 
pharmaceutical-grade raw materials under strict quality and safety standards.

* Effects of high-dose docosahexaenoic acid supplementation as an add-on 
therapy for canine idiopathic epilepsy: A pilot study.Open Vet J. 2023 Jul; 
13(7): 942-947.

Research Collaboration on Canine Idiopathic Epilepsy

In parallel with the product launch, Zpeer Inc. has entered into a joint 
research agreement, effectiveNovember 27, 2025, with the Laboratory of 
Veterinary Clinical Pathology, Graduate School of Agricultural and Life 
Sciences, theUniversity of Tokyo. The research will focus on generating more 
robust clinical evidence through structured clinical studies, including 
evaluation of seizure outcomes and quality of life (QOL) in affected dogs. The 
goal is to clarify the clinical relevance of high-concentration DHA as part of 
nutritional management strategies for canine epilepsy.

"Previous case observations suggested a potential role for DHA in reducing 
seizure frequency, but many clinical questions remain," said Associate 
Professor Yonezawa. "This collaboration will allow us to systematically 
evaluate its effects in real-world clinical settings and contribute more 
rigorous evidence to the field of veterinary neurology."

About A-DHA-PT™

A-DHA-PT™ is available in Japan through "Animato," Zpeer's veterinary 
e-commerceplatform, which connects pet owners with products endorsed by their 
primary veterinary clinics. Owners must register their primaryveterinary clinic 
to purchase the product.

About Zpeer Inc.

Zpeer Inc. develops veterinary informational, educational and commercial 
platforms and therapeutic solutions that support veterinary professionals and 
advance animal healthcare through clinical evidence and data-driven approaches. 
The company's mission is to help create a healthier future for both animals and 
the people who care for them.

Company Website: https://zpeer.info/en/ <https://zpeer.info/en/>

]]></description>
		<detail><![CDATA[<p><span class="legendSpanClass"><span class="xn-location">TOKYO</span></span>, <span class="legendSpanClass"><span class="xn-chron">Jan. 6, 2026</span></span> /PRNewswire/ -- Zpeer Inc. (Headquarters: Shibuya, <span class="xn-location">Tokyo</span>; CEO: <span class="xn-person">Toshiya Morino</span>), an animal health company focused on evidence-based <span id="spanHghlt3ab3">therapeutic</span> innovation, has recently announced the launch of A-DHA-PT™ (pronounced &quot;ay-dapt&quot;), a high-concentration DHA supplement designed to support canine neurological health. The company also disclosed a new research collaboration with the <span class="xn-org">University of Tokyo</span> aimed at further validating the clinical benefits of DHA in dogs with idiopathic epilepsy.</p> 
<p>A-DHA-PT™ was developed to address growing clinical interest in nutritional approaches to neurological conditions in companion animals. Each compact 13 mm capsule delivers a high dose of over 150 mg of DHA, enabling efficient administration while minimizing pill burden for dogs. The product is available in bags containing 120 capsules.</p> 
<p>The product's formulation is based on prior academic research* and has been developed under the scientific supervision of Dr. <span class="xn-person">Tomohiro Yonezawa</span>, Associate Professor of the <span class="xn-org">University of Tokyo</span>. A-DHA-PT™ is manufactured in <span class="xn-location">Japan</span> using pharmaceutical-grade raw materials under strict quality and safety standards.</p> 
<p>* Effects of high-dose docosahexaenoic acid supplementation as an add-on therapy for canine idiopathic epilepsy: A pilot study. <i>Open Vet J.</i> 2023 Jul; 13(7): 942-947.</p> 
<p><b>Research Collaboration on Canine Idiopathic Epilepsy</b></p> 
<p>In parallel with the product launch, Zpeer Inc. has entered into a joint research agreement, effective <span class="xn-chron">November 27, 2025</span>, with the Laboratory of Veterinary Clinical Pathology, Graduate School of Agricultural and Life Sciences, the <span class="xn-org">University of Tokyo</span>. The research will focus on generating more robust clinical evidence through structured clinical studies, including evaluation of seizure outcomes and quality of life (QOL) in affected dogs. The goal is to clarify the clinical relevance of high-concentration DHA as part of nutritional management strategies for canine epilepsy.</p> 
<p class="prnml40">&quot;Previous case observations suggested a potential role for DHA in reducing seizure frequency, but many clinical questions remain,&quot; said Associate Professor Yonezawa. &quot;This collaboration will allow us to systematically evaluate its effects in real-world clinical settings and contribute more rigorous evidence to the field of veterinary neurology.&quot;</p> 
<p><b>About A-DHA-PT™</b></p> 
<p>A-DHA-PT™ is available in <span class="xn-location">Japan</span> through &quot;Animato,&quot; Zpeer's&nbsp;<span id="spanHghlt2245">veterinary e-commerce </span>platform, which connects pet owners with products endorsed by their primary veterinary clinics. Owners must register their primary <span id="spanHghltd9d8">veterinary clinic</span> to purchase the product.</p> 
<p><b>About Zpeer Inc.</b></p> 
<p>Zpeer Inc. develops veterinary informational, educational and commercial platforms and therapeutic solutions that support veterinary professionals and advance animal healthcare through clinical evidence and data-driven approaches. The company's mission is to help create a healthier future for both animals and the people who care for them.</p> 
<p><b>Company Website:</b> <a href="https://zpeer.info/en/" target="_blank" rel="nofollow" style="color: #0000FF">https://zpeer.info/en/</a></p>]]></detail>
		<source><![CDATA[Zpeer Inc.]]></source>
	</item>
	
</channel>
</rss>